Presentation Preview: Assessing the Mechanism & PD Characterization of Conditionally Active Biologics Leveraging the TME to Improve ADC Therapeutic Index
- Highlighting the benefits and potential of conditionally activated ADCs against traditional conjugate design
- Exploring Conditionally Active Biologic mechanism leveraging tumor pH and physiological conditions for ADC activation
- Spotlighting PD profiles of conditionally active ADCs to demonstrate improved therapeutic index